Best-in-class development and manufacturing services for viral vectors and nucleic acids
WHO WE ARE
Full-service Contract Development and Manufacturing Organization
Exothera is a Belgium-based CDMO delivering customized process development and GMP manufacturing services for viral vector (AAV, AV, HSV, LVV, …) and mRNA projects. As a Univercells company, Exothera capitalizes on novel manufacturing technologies and best-in-class bioprocessing expertise to provide bespoke process optimization and GMP clinical and commercial production of viral vectors and nucleic acids.
WHO WE ARE
Full-service Contract Development and Manufacturing Organization
Exothera is a Belgium-based CDMO delivering customized process development and GMP manufacturing services for viral vector (AAV, AV, HSV, LVV, …) and mRNA projects. As a Univercells company, Exothera capitalizes on novel manufacturing technologies and best-in-class bioprocessing expertise to provide bespoke process optimization and GMP clinical and commercial production of viral vectors and nucleic acids.
WHAT WE DO
Our Services
We support your cell and gene product, viral vaccine or oncolytic virus therapy development from pre-clinical to cGMP manufacturing.
Our core services are AAV and AV development and manufacturing with extra expertise in VLP, MVA, LVV, baculovirus, and others.
WHAT WE DO
Our Services
We support your cell and gene product, viral vaccine or oncolytic virus therapy development from pre-clinical to cGMP manufacturing. Our core services are AAV and AV development and manufacturing with extra expertise in VLP, MVA, LVV, baculovirus, and others.
TESTIMONIALS
What our customers think about our services
We are extremely satisfied with Exothera’s manufacturing capabilities, the full-service model, and the outstanding commitment to rapid manufacturing of our vaccine for the Phase I/II trials. This is everything we need from a CDMO.
We chose Exothera because we recognise the benefits of having a partner with extensive process design experience to rapidly scale the production of our novel COVID-19 vaccine candidate, CVXGA1. Exothera will enable us to produce millions of doses of our intranasal vaccine for Phase III trials.
These are impressive data. I am very happy. I would say that with Exothera I had one of the best CDMO experiences ever.
Client satisfaction rate
2,100
square meters of GMP area
32
viral projects (AAV, adeno, etc.)
200-600
square meters fixed bed
2,000
liters scale stirred tanks
+150
collaborators
120
million euros of funds raised by Univercells
WHERE WE WORK
Our Facilities
Exothera is located in the heart of Europe in Belgium (Nivelles and Jumet), just a stone’s throw from Brussels South Airport.
WHERE WE WORK
Our Facilities
Exothera is located in the heart of Europe in Belgium (Nivelles and Jumet), just a stone’s throw from Brussels South Airport.
Designing & delivering bespoke bioproduction journeys for innovators to achieve successful market entry
OUR APPROACH
Our Differentiators
Tailored journey to commercial manufacturing
Flexible and highly qualitative approach to accommodate projects at all stages of development.
Continuous adoption of state-of-the-art technologies
Technology selection for cost-effective virus manufacturing.
Bioprocessing expertise
Data-driven process optimization for cost-effectiveness & high performance.
OUR APPROACH
Our Differentiators
Tailored journey to commercial manufacturing
Flexible and highly qualitative approach to accommodate projects at all stages of development.
Continuous adoption of state-of-the-art technologies
Technology selection for cost-effective virus manufacturing.
Bioprocessing expertise
Data-driven process optimization for cost-effectiveness & high performance.
Trusted by
